Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Nektar Therapeutics Total Assets 2010-2025 | NKTR

Nektar Therapeutics total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
  
Nektar Therapeutics Annual Total Assets
(Millions of US $)
2024 $304
2023 $398
2022 $711
2021 $1,117
2020 $1,539
2019 $1,977
2018 $2,150
2017 $509
2016 $569
2015 $499
2014 $442
2013 $435
2012 $498
2011 $607
2010 $521
2009 $576
Nektar Therapeutics Quarterly Total Assets
(Millions of US $)
2025-03-31 $256
2024-12-31 $304
2024-09-30 $308
2024-06-30 $343
2024-03-31 $396
2023-12-31 $398
2023-09-30 $442
2023-06-30 $494
2023-03-31 $562
2022-12-31 $711
2022-09-30 $781
2022-06-30 $862
2022-03-31 $1,024
2021-12-31 $1,117
2021-09-30 $1,277
2021-06-30 $1,371
2021-03-31 $1,457
2020-12-31 $1,539
2020-09-30 $1,509
2020-06-30 $1,595
2020-03-31 $1,888
2019-12-31 $1,977
2019-09-30 $2,088
2019-06-30 $2,100
2019-03-31 $2,166
2018-12-31 $2,150
2018-09-30 $2,249
2018-06-30 $2,313
2018-03-31 $497
2017-12-31 $509
2017-09-30 $582
2017-06-30 $476
2017-03-31 $528
2016-12-31 $569
2016-09-30 $425
2016-06-30 $463
2016-03-31 $492
2015-12-31 $499
2015-09-30 $449
2015-06-30 $457
2015-03-31 $499
2014-12-31 $442
2014-09-30 $477
2014-06-30 $478
2014-03-31 $487
2013-12-31 $435
2013-09-30 $383
2013-06-30 $413
2013-03-31 $448
2012-12-31 $498
2012-09-30 $541
2012-06-30 $668
2012-03-31 $695
2011-12-31 $607
2011-09-30 $648
2011-06-30 $671
2011-03-31 $704
2010-12-31 $521
2010-09-30 $502
2010-06-30 $531
2010-03-31 $549
2009-12-31 $576
2009-09-30 $453
2009-06-30 $473
2009-03-31 $506
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.141B $0.098B
Nektar Therapeutics is a biopharmaceutical company, focused on the development of treatments utilizing its PEGylation and advanced polymer conjugate technology platforms. Nektar primarily finances its operations with funds from licensing, collaboration and manufacturing agreements. It has collaboration deals with companies namely AstraZeneca, Pfizer, Roche, Amgen, Bristol-Myers and Eli Lilly among others. The company's most lucrative deal is with Bristol-Myers, which provided the company with significant cash resources to support progress of its pipeline and share development costs for its lead candidate, bempegaldesleukin. Nektar recognizes product sales from its manufacturing and supply agreements with several pharma companies related to products developed using its PEGylation platform. The company also earns royalty payments from the sales of products using its technology platforms. Amgen's neutropenia drug, Neulasta is one of the drugs developed using Nektar's PEGylation platform.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $86.949B 32.62
Zoetis (ZTS) United States $74.394B 27.76
Takeda Pharmaceutical (TAK) Japan $48.493B 9.65
Daiichi Sankyo, - (DSNKY) Japan $47.908B 24.55
BeOne Medicines - (ONC) Cayman Islands $28.843B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.294B 0.00
Merck (MKKGY) Germany $17.183B 12.59
Summit Therapeutics (SMMT) United States $16.398B 0.00
Shionogi (SGIOY) Japan $14.377B 14.40
United Therapeutics (UTHR) United States $12.691B 11.23
Neurocrine Biosciences (NBIX) United States $12.348B 42.29
IPSEN (IPSEY) France $10.086B 0.00
Orion OYJ (ORINY) Finland $10.083B 27.27
Corcept Therapeutics (CORT) United States $7.664B 62.30
Stevanato Group S.p.A (STVN) Italy $7.462B 45.63
Madrigal Pharmaceuticals (MDGL) United States $6.268B 0.00
Grifols, S.A (GRFS) Spain $6.202B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ionis Pharmaceuticals (IONS) United States $5.863B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.980B 15.15
Soleno Therapeutics (SLNO) United States $4.021B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.209B 11.24
Hypermarcas (HYPMY) Brazil $3.110B 20.46
Crinetics Pharmaceuticals (CRNX) United States $3.097B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.452B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.448B 13.24
BioCryst Pharmaceuticals (BCRX) United States $2.304B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.215B 0.00
Indivior (INDV) United States $1.888B 8.01
Dyne Therapeutics (DYN) United States $1.680B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.619B 0.00
Evotec AG (EVO) Germany $1.467B 0.00
ARS Pharmaceuticals (SPRY) United States $1.443B 0.00
Ocular Therapeutix (OCUL) United States $1.419B 0.00
Guardian Pharmacy Services (GRDN) United States $1.306B 0.00
Harrow (HROW) United States $1.143B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.101B 22.03
Enliven Therapeutics (ELVN) United States $1.065B 0.00
Akebia Therapeutics (AKBA) United States $1.030B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.990B 0.00
Collegium Pharmaceutical (COLL) United States $0.976B 5.26
Ardelyx (ARDX) United States $0.895B 0.00
Cronos Group (CRON) Canada $0.752B 0.00
Elite Pharmaceuticals (ELTP) United States $0.748B 0.00
Xeris Biopharma Holdings (XERS) United States $0.712B 0.00
KalVista Pharmaceuticals (KALV) United States $0.706B 0.00
Xencor (XNCR) United States $0.693B 0.00
Relay Therapeutics (RLAY) United States $0.598B 0.00
AleAnna (ANNA) United States $0.584B 0.00
Liminatus Pharma (LIMN) United States $0.583B 0.00
USANA Health Sciences (USNA) United States $0.575B 12.49
Regulus Therapeutics (RGLS) United States $0.575B 0.00
Verve Therapeutics (VERV) United States $0.569B 0.00
Bioventus (BVS) United States $0.564B 14.29
Altimmune (ALT) United States $0.547B 0.00
Theravance Biopharma (TBPH) United States $0.537B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.513B 0.00
Zevra Therapeutics (ZVRA) United States $0.507B 0.00
Oruka Therapeutics (ORKA) United States $0.494B 0.00
Tourmaline Bio (TRML) United States $0.488B 0.00
Siga Technologies (SIGA) United States $0.444B 9.28
Organogenesis (ORGO) United States $0.440B 0.00
Savara (SVRA) United States $0.403B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.385B 10.41
Aquestive Therapeutics (AQST) United States $0.356B 0.00
Heron Therapeutics (HRTX) United States $0.323B 0.00
ProKidney (PROK) United States $0.293B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.276B 0.00
Nature's Sunshine Products (NATR) United States $0.264B 24.24
Esperion Therapeutics (ESPR) United States $0.242B 0.00
MediWound (MDWD) Israel $0.230B 0.00
Nanobiotix S.A (NBTX) France $0.229B 0.00
4D Molecular Therapeutics (FDMT) United States $0.207B 0.00
Profound Medical (PROF) Canada $0.203B 0.00
OmniAb (OABI) United States $0.188B 0.00
Larimar Therapeutics (LRMR) United States $0.186B 0.00
Journey Medical (DERM) United States $0.170B 0.00
Aclaris Therapeutics (ACRS) United States $0.164B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.162B 0.00
Aldeyra Therapeutics (ALDX) United States $0.161B 0.00
Lyell Immunopharma (LYEL) United States $0.160B 0.00
Avita Medical (RCEL) United States $0.158B 0.00
Lexeo Therapeutics (LXEO) United States $0.153B 0.00
Inhibikase Therapeutics (IKT) United States $0.149B 0.00
Korro Bio (KRRO) United States $0.149B 0.00
Protara Therapeutics (TARA) United States $0.130B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.129B 0.00
Achieve Life Sciences (ACHV) Canada $0.128B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Cardiol Therapeutics (CRDL) Canada $0.120B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.113B 0.00
Fractyl Health (GUTS) United States $0.106B 0.00
Cassava Sciences (SAVA) United States $0.105B 0.00
Wellgistics Health (WGRX) United States $0.102B 0.00
Inotiv (NOTV) United States $0.098B 0.00
OptiNose (OPTN) United States $0.097B 0.00
VAXART, INC (VXRT) United States $0.090B 0.00
Arch Biopartners (ACHFF) Canada $0.090B 0.00
Champions Oncology (CSBR) United States $0.089B 14.68
Nutriband (NTRB) United States $0.086B 0.00
Galectin Therapeutics (GALT) United States $0.085B 0.00
Pyxis Oncology (PYXS) United States $0.083B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.082B 61.22
Dominari Holdings (DOMH) United States $0.080B 0.00
Surrozen (SRZN) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Rafael Holdings (RFL) United States $0.071B 0.00
Vivani Medical (VANI) United States $0.069B 0.00
Klotho Neurosciences (KLTO) United States $0.065B 0.00
Unicycive Therapeutics (UNCY) United States $0.064B 0.00
Assertio Holdings (ASRT) United States $0.063B 0.00
NRx Pharmaceuticals (NRXP) United States $0.063B 0.00
PMV Pharmaceuticals (PMVP) United States $0.062B 0.00
Telomir Pharmaceuticals (TELO) United States $0.061B 0.00
Prelude Therapeutics (PRLD) United States $0.061B 0.00
Context Therapeutics (CNTX) United States $0.060B 0.00
Metagenomi (MGX) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Gain Therapeutics (GANX) United States $0.057B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.056B 0.00
Century Therapeutics (IPSC) United States $0.055B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Carisma Therapeutics (CARM) United States $0.046B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
ElectroCore (ECOR) United States $0.043B 0.00
Iterum Therapeutics (ITRM) Ireland $0.042B 0.00
Acrivon Therapeutics (ACRV) United States $0.040B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.039B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
China SXT Pharmaceuticals (SXTC) China $0.033B 0.00
Tempest Therapeutics (TPST) United States $0.033B 0.00
Jupiter Neurosciences (JUNS) United States $0.032B 0.00
FibroGen (FGEN) United States $0.031B 0.00
Relmada Therapeutics (RLMD) United States $0.026B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.023B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Lyra Therapeutics (LYRA) United States $0.021B 0.00
BioVie (BIVI) United States $0.020B 0.00
Mannatech (MTEX) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.019B 0.00
DURECT (DRRX) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Scienture Holdings (SCNX) United States $0.015B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.20
Vivos Therapeutics (VVOS) United States $0.012B 0.00
Ainos (AIMD) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
GlycoMimetics (GLYC) United States $0.011B 0.00
Citius Pharmaceuticals (CTXR) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
SHINECO (SISI) China $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
PainReform (PRFX) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00